The Palomino Group Announces Launch of Meeting Support Services Business Unit

The Palomino Group, a leading commercialization and reimbursement services organization, today announced the launch of its new Meeting Support Services business unit targeted to the biopharmaceutical industry. The company, based in Minneapolis, MN offers comprehensive reimbursement and commercialization consulting services that support biotechnology, pharmaceutical, medical device, and other healthcare companies.

Minneapolis, MN (PRWEB / PRWEB) July 24, 2008 -- The Palomino Group, a leading commercialization and reimbursement services organization, today announced the launch of its new Meeting Support Services business unit targeted to the biopharmaceutical industry. The company, based in Minneapolis, MN offers comprehensive reimbursement and commercialization consulting services that support biotechnology, pharmaceutical, medical device, and other healthcare companies.

The Palomino Group has continued to diversify the types of services and support that it offers to meet the growing needs of biopharmaceutical client companies. Since launching the company's commercialization and reimbursement consulting business, the Palomino Group has significantly expanded its business opportunities and currently supports numerous biopharmaceutical products in the pre-launch development, launch, and post-launch commercial settings.

"In view of the current environment and the projected landscape within the biopharmaceutical arena over the next few years, there is an expanding need for commercialization and reimbursement consulting services within the marketplace," said Charles Griffin, Co-Founder and Principal of the Palomino Group. "We believe that the launch of our new Meeting Support Services business unit is a natural evolution of our current capabilities and consulting service offerings to current and future client customers. Our clients are increasingly outsourcing capabilities to support these types of clinical and commercial needs, and are seeking consulting groups that possess a comprehensive understanding of all of these critical capabilities."

Under the Meeting Support Services umbrella, the Palomino Group will offer client companies a full menu of meeting and program services to allow for the execution of high quality clinical and scientific advisory boards, investigator meetings, symposia, reimbursement and managed markets advisory sessions, and other clinical, scientific, and commercial programs. "We are finding that the healthcare arena has evolved to the point where there is significant integration and overlap of clinical, commercial, and payer considerations. Manufacturers are seeking consultant experts that understand these critical issues and points of integration in order to better develop strategies and programs that are more closely aligned with issues impacting key thought leaders, policy makers, and the healthcare marketplace," said Jan Palmer, Co-Founder and Principal of the Palomino Group.

In addition to its new Meeting Support Services, the Palomino Group offers a variety of Reimbursement and Commercialization consulting support services, including:

Strategic Reimbursement Analyses

Market Assessments

Product Coverage Introductions

Payer Advocacy

Coding and Pricing Support

Legislative and Policy Monitoring

Qualitative Reimbursement Research

Managed Markets Development

Strategic Market Planning

Launch Plan Development

Pricing & Contracting Strategy

Strategic Life Cycle Development

Commercial Operation Design & Budgeting

About The Palomino Group
The Palomino Group (The Palomino Group Health Care Consultants, LLC) is a leading service provider that offers commercialization and reimbursement consulting services to biotechnology, pharmaceutical, medical device, and other healthcare companies. Based in Minneapolis, the company works with client healthcare companies to provide expert commercialization and reimbursement support services for new and existing drugs, biologics, and healthcare technologies. The company is heavily focused within oncology and other key disease arenas. Additional information about the Palomino Group is available on their website at http://www.palominogroup.com.